The Food and Drug Administration is tired of waiting. Of the 11 biosimilars approved by the agency, only three are available on the U.S.
What stands between patients and integrative, comprehensive pain management? It could be health plan design, according to a recent attitudinal survey by the Alliance for
In a week already marked by fireworks and parades, patients in Maine have one more thing to celebrate. A new state law draws clear lines
What can America learn at the crossroads of social media and clinical trials? At a recent National Institutes of Health workshop, one organization had a
Massachusetts Medicaid patients are breathing a collective sigh of relief. Federal officials announced this week that Massachusetts will not be allowed to restrict which drugs
The Food and Drug Administration has approved two generic versions of an innovative drug to treat opioid addiction, increasing available treatment options for Americans fighting